Hope for preventing stomach cancer
Approximately 43 percent of the world’s population is infected with this bacterium. It can cause chronic inflammation of the stomach lining, lead to gastric ulcers, and is considered a key risk factor for stomach cancer. Standard therapies are primarily based on the antibiotic metronidazole. However, H. pylori is becoming increasingly resistant to it. As a result, ever higher doses and combinations with additional antibiotics are required.
The team led by Prof. Stephan A. Sieber, Chair of Organic Chemistry II at the TUM School of ...